GPER1 and neoplasm: Furthermore, the estrogen/GPR30/cAMP/PKA/CREB signaling axis was confirmed to trigger aerobic glycolysis switch in CAFs, introducing a "host-parasite" pattern into tumor cells, thereby causing them to exhibit resistance to several conventional drugs, including Tamoxifen [6].